JBF Capital’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

JBF Capital’s Portfolio LABU Stock Details LABU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,000	Closed	-$720K	–	84
2021 Q4	$720K	Buy	+1,000	New	+$957K	0.14%	32
2019 Q1	–	Sell	-500	Closed	-$329K	–	92
2018 Q4	$329K	Buy	+500	New	+$524K	0.06%	41

Other funds holding LABU

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

TCM

Traynor Capital Management Malvern, Pennsylvania $1.7B AUM 39.15% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Wolverine Trading Chicago, Illinois $139B AUM 31.83% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Cutler Group San Francisco, California $307M AUM 45.11% 1-Year Est. Return

RCM

Requisite Capital Management Dallas, Texas $537M AUM 12.29% 1-Year Est. Return

JBF Capital's LABU Position: Q1 2022 in Review

JBF Capital sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q1 2022, closing a stake of 1,000 shares — an estimated $720K sold.

JBF Capital first reported a position in LABU in Q4 2018 and held it in 2 quarters. The position peaked at $720K in Q4 2021. 32 funds tracked by Wall St. Rank hold LABU as of Q1 2022.

JBF Capital reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q1 2022 after selling out during the quarter.
JBF Capital sold 1,000 Direxion Daily S&P Biotech Bull 3X ETF shares in Q1 2022, an estimated $720K.
JBF Capital first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q4 2018 and held it in 2 quarters.
JBF Capital's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $720K in Q4 2021.
32 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q1 2022.

Based on JBF Capital's 13F filing for Q1 2022, filed 16 May 2022.